Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daron Ferris

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Causes & Control : CCC|September 2, 2003
Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, MexicoJorge Salmerón, Eduardo Lazcano-Ponce, Attila Lorincz, et al.
The New England Journal of Medicine|October 28, 2011
HPV vaccine against anal HPV infection and anal intraepithelial neoplasiaJoel M Palefsky, Anna R Giuliano, Stephen Goldstone, et al.
The New England Journal of Medicine|February 4, 2011
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in malesAnna R Giuliano, Joel M Palefsky, Stephen Goldstone, et al.
Pediatrics|January 2, 2021
Three-Year Follow-up of 2-Dose Versus 3-Dose HPV VaccineJacob Bornstein, Surita Roux, Lone Kjeld Petersen, et al.
Pediatrics|July 17, 2016
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical TrialsEdson D Moreira, Stan L Block, Daron Ferris, et al.
Papillomavirus Research (Amsterdam, Netherlands)|July 20, 2017
Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trialsLone K Petersen, Jaime Restrepo, Edson D Moreira, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 3, 2014
Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical diseaseElmar A Joura, Kevin A Ault, F Xavier Bosch, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Causes & Control : CCC|September 2, 2003
Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, MexicoJorge Salmerón, Eduardo Lazcano-Ponce, Attila Lorincz, et al.
The New England Journal of Medicine|October 28, 2011
HPV vaccine against anal HPV infection and anal intraepithelial neoplasiaJoel M Palefsky, Anna R Giuliano, Stephen Goldstone, et al.
The New England Journal of Medicine|February 4, 2011
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in malesAnna R Giuliano, Joel M Palefsky, Stephen Goldstone, et al.
Pediatrics|January 2, 2021
Three-Year Follow-up of 2-Dose Versus 3-Dose HPV VaccineJacob Bornstein, Surita Roux, Lone Kjeld Petersen, et al.
Pediatrics|July 17, 2016
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical TrialsEdson D Moreira, Stan L Block, Daron Ferris, et al.
Papillomavirus Research (Amsterdam, Netherlands)|July 20, 2017
Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trialsLone K Petersen, Jaime Restrepo, Edson D Moreira, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 3, 2014
Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical diseaseElmar A Joura, Kevin A Ault, F Xavier Bosch, et al.
Pageof 3